About this episode

The episode features an 'Ask me anything' format with EUCAST and CLSI leadership discussing their roles and operations.

In this episode of Communicable , Nav Narayanan and Thomas Tängdén kick off the first 'Ask me anything' episode, inviting EUCAST and CLSI leadership Sören Gatermann, Christian Giske and Amy Mathers to answer questions from our listeners. Together, they discuss the roles and operations of both organisations, similarities and differences between EUCAST and CLSI, how breakpoints and guidance documents are developed, set the record straight about the 'I' category, explain which data inform breakpoint decisions, and much more. This episode was edited by Communicable 's executive producer, Angela Huttner. Further reading Documents/resources: CLSI MicroFree, https://em100.edaptivedocs.net/Login.aspx?ru=1 EUCAST: When there are no antifungal breakpoints EUCAST: When there are no breakpoints? Use_of_fosfomycin_iv_breakpoints_General_advice_20240528.pdf EUCAST: Definition of S, I and R EUCAST Guidance Document, “When there are no breakpoints”, https://www.eucast.org/bacteria/guidance-documents/ EUCAST Guidance Document for “Rare Yeasts”, https://www.eucast.org/fungi-afst/guidance-documents/ Articles (alphabetical): Bixby ML, et al. Fosfomycin Disk Diffusion Testing among Klebsiella…

People in this episode

Hosts: Nav Narayanan, Thomas Tängdén

Guests: Sören Gatermann, Christian Giske, Amy Mathers

Topics covered

• EUCAST
• CLSI
• breakpoints
• guidance documents
• antifungal breakpoints

Keywords

• EUCAST
• CLSI
• breakpoints
• guidance documents
• antifungal

Mentioned in this episode

Organizations: EUCAST, CLSI

More episodes of Communicable

• Communicable E62: The 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditis · September 6, 2026 · 52 min
• Communicable E61: We will make you love PK/PD, part 3 · August 23, 2026 · 53 min
• Communicable E60: Quarterly catch-up (August 2026 edition) · August 9, 2026 · 49 min
• Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened · July 12, 2026 · 54 min
• Communicable E57: We will make you love PK/PD, part 2 · June 28, 2026 · 47 min
• Communicable E56: Frequentist vs Bayesian for clinical trial analysis – 99% probability you’ll want to listen to this · June 14, 2026 · 1h 5m

Explore listener stats, chart rankings, contacts and more on the Communicable podcast page.